Major outer membrane protein of Chlamydia trachomatis (MOMP) (MOMP)

The Major Outer Membrane Protein (MOMP) of Chlamydia trachomatis is a 40-kDa integral membrane protein that serves as a primary structural component and a porin for the bacterium (UniProt: P06597). It constitutes approximately 60% of the total outer membrane protein mass and is essential for maintaining the structural integrity of the elementary body, the infectious form of the organism (PubMed: 29153244). MOMP functions as a porin, allowing the diffusion of small molecules and nutrients across the outer membrane, which is vital for the pathogen's metabolic activity. It also plays a significant role in host cell attachment and entry, making it a critical virulence factor (StatPearls: Chlamydia Trachomatis). Due to its high surface exposure and presence across various serovars, MOMP is the most widely studied target for Chlamydia vaccine development, such as the CTH522 candidate (PubMed: 31405965). In diagnostic medicine, it is the primary antigen detected in direct fluorescent antibody (DFA) tests and enzyme-linked immunosorbent assays (ELISA) to identify active infections. Therapeutic strategies targeting MOMP focus on eliciting neutralizing antibodies that block the interaction between the bacterium and host epithelial cells. However, the high degree of sequence variation in the protein's variable domains across different serovars presents a significant challenge for universal vaccine design.

Other names

MOMPOMP1Outer membrane protein 1Chlamydial antigenMajor outer membrane protein

Vaccine-induced production of neutralizing antibodies and T-cell responses to prevent bacterial entry and promote clearance (PubMed: 31405965).